Practical Guide to Peritoneal Malignancy

The PMI Manual

Inbunden, Engelska, 2019

3 459 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Peritoneal malignancy is a rapidly growing field within surgical oncology. National and International treatment programmes and training curricula are being established worldwide to co-ordinate treatment and management of these challenging clinical problems. A large body of evidence now exists, but the practical implications of this evidence base remain unclear. The Peritoneal Malignancy Institute in Basingstoke, the largest centre in the world, is at the forefront of new developments and techniques. This manual combines the experience of the PMI with the latest evidence to provide a practice-oriented guide to the successful set up and running of a peritoneal malignancy unit.

Produktinformation

Utgivningsdatum2019-12-16
Mått189 x 246 x 18 mm
Vikt622 g
FormatInbunden
SpråkEngelska
Antal sidor214
FörlagTaylor & Francis Ltd
ISBN9781138495050

Tillhör följande kategorier

Onkologi inom Medicin
Kirurgi inom Medicin
Gastrointestinal och kolorektal kirurgi inom Medicin

Tom Cecil is Clinical Director at the Peritoneal Malignancy Institute, Basingstoke, Hampshire Hospitals NHS Foundation Trust and Honorary Transplant Surgeon, Oxford University Hospitals, Oxford, UK.John Bunni is a Consultant Colorectal and General Surgeon, Royal United Hospital, Bath, UK. He is also Visiting Lecturer, University of Bath, UK; Honorary Lecturer, Cardiff University, UK and was awarded the ASGBI Gold Medal.Akash Mehta is Consultant Colorectal Surgeon at St Mark’s Hospital & Academic Institute, London, UK and holds the ESSO European Certification in Peritoneal Surface Oncology.

SET: UNDERSTANDING AND ASSESSMENT OF PERITONEAL DISEASE. Appendix tumours and pseudomyxoma peritonei: A ‘paradigm’ for peritoneal disease. Colorectal peritoneal metastases. Peritoneal mesothelioma. Miscellaneous peritoneal malignancies. Quantitative assessment of peritoneal disease. Imaging in peritoneal malignancy. DIALOGUE: INTRAPERITONEAL CHEMOTHERAPY AND CYTOREDUCTIVE SURGERY. Intraperitoneal chemotherapy. Perioperative and anaesthetic care. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Postoperative care. Postoperative complications. CLOSURE: ONGOING CARE AND FUTURE MANAGEMENT OPTIONS. Histopathological aspects of peritoneal malignancy. Follow-up protocols in peritoneal malignancy. Recurrence of pseudomyxoma peritonei. Future perspectives in peritoneal malignancy.